RecruitingNCT05928767

Evaluation of the Clinical Frailty Scale (CFS) as a Risk Factor of Mortality in Adult Patients ≤65 Years of Age Admitted to Intensive Care for Septic Shock.


Sponsor

Centre Hospitalier de Lens

Enrollment

200 participants

Start Date

Aug 21, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of the study is to demonstrate that "frail" patients, defined as having a CFS score greater than or equal to 5, and "severely" frail patients, defined as having a CFS score between \[6-7\] as defined by Bagshaw et al (14), constitute an independent risk factor (RF) for mortality. In the same way, as an exploratory study, we will try to find out whether clinical frailty constitutes a risk factor for extending the length of hospital stay, the risk of short/medium-term readmission, as has already been demonstrated for patients admitted to intensive care from all causes (15), or for impaired quality of life. The objective is to have a better understanding of the implications and outcomes associated with pre-hospital frailty in young critically ill patients. This analysis will also help to clarify prognoses and contribute to better decision-making on the intensity and proportionality of care, as well as providing better information and helping to manage the expectations of patients and their families in terms of survival prognosis and subsequent quality of life.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria5

  • Patients aged ≥18 years and ≤ 65 years
  • Patient admitted to intensive care - resuscitation
  • Patient admitted for suspected or documented type 3 sepsis
  • Presence of vasopressor amines to maintain MAP > 65mmHg despite filling
  • Lactatemia ≥ 2 mmol/L on admission.

Exclusion Criteria6

  • Patient moribund on admission
  • Patients with severe pre-existing dementia and/or cognitive decline, suffering from severe neurodegenerative diseases that prevent the patient from living independently at baseline, including mental illness requiring institutionalisation, including acquired or congenital mental retardation, etc.
  • Pregnant women or women in labour
  • Patients under guardianship or curatorship
  • Patients deprived of their liberty
  • Patient and/or family unable to speak or understand French.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(5)

Ch Germon Et Gauthier

Béthune, France

CH Boulogne sur Mer

Boulogne-sur-Mer, France

CHU de Dijon

Dijon, France

CH de Lens

Lens, France

CHU Lille

Lille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05928767


Related Trials